Iran approves Russian vaccine Sputnik Light

The Russian single-component CORONAVIRUS vaccine Sputnik Light has been approved for use in Iran. This is stated in a message received by RBC from the Russian Direct Investment Fund (RDIF), which promotes development abroad.

The foundation noted that the widespread use of Sputnik Light will speed up the vaccination of people and help to form population immunity faster. In addition, earlier, RDIF recalled, the high efficacy and safety of the vaccine was reported by the Ministries of HEALTH of Argentina (efficiency of about 78.6-83.7% when vaccinating elderly people aged 60 to 79 years) and Paraguay (93.5% effectiveness). during mass vaccination).

When RUSSIA is going to deliver Sputnik Light to Iran, the message does not indicate.

"Sputnik Light" is a one-component vaccine created by the Center. Gamaleya based on the two-component preparation for covid-19 "Sputnik V". Like Sputnik V, Sputnik Light operates on the basis of recombinant human adenovirus serotype 26 (rAd26).